TNFRSF17 and Miyoshi myopathy: The functionality of CARs B1 and B2 was evaluated in an overnight cytotoxicity assay against two multiple myeloma (MM) cell lines, MM.1S and RPMI-8226, both positive for BCMA expression (Figure 1D, Supplementary Figure 1B).